Compare uniQure N.V. Ordinary Shares (QURE) vs Block Inc (XYZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Block Inc — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while Block Inc trades at $75.45 (market cap $46.18B). The key difference: Block Inc is far larger — about 31.2× uniQure N.V. Ordinary Shares's market cap, and Block Inc is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Block Inc for 78 Days on average.
| QURE | XYZ | |
|---|---|---|
Market Cap | $1.48B | $46.18B |
Volume | 2,488,780 | 4,211,951 |
Sector | Health | Technology |
52-Week High | $70.59 | $84.85 |
52-Week Low | $9.03 | $49.04 |
Typical Hold Time | 0 Days | 78 Days |
Enterprise Value | $728.62M | $41.08B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XYZ trades at $76.83, up 0.04% today, with a bullish technical signal and strong analyst support. Recent earnings beat expectations in Q1 and Q2 2026, though net income margin remains thin at 1.43%. The company shows robust revenue growth, reaching $24.19 billion in 2025, and is expanding through partnerships and a potential national trust bank application, positioning it for future growth amid competitive fintech pressures.
The outlook is positive with a consensus price target of $97.47, implying 27% upside, but risks include high P/E valuation, insider selling, and reliance on competitive digital payment markets. Execution on revenue growth and margin improvement will be critical for sustaining investor confidence and stock performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Block Inc
Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →
